A PHARMACOKINETIC STUDY TO ASSESS THE INFLUENCE OF P-GLYCOPROTEIN INHIBITION AND SIMULTANEOUS CYP3A4 AND P-GLYCOPROTEIN INDUCTION ON E7080 PHARMACOKINETICS FOLLOWING SINGLE DOSE ORAL ADMINISTRATION OF 24 MG E7080 TO HEALTHY VOLUNTEERS: